A10364 | Pages: NA | Jul 2022 | 700 Views | | |
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Photobiostimulation Devices Market
Request Now !Photobiostimulation is a low-level light therapy (LLLT) widely used for minimizing inflammation, edema, and pain. This technique uses LEDs to emit light at different wavelengths such as infrared and red light. With help of this light it helps to heal wounds, nerves and deeper tissues and prevents tissue damage. Photobiostimulation devices emit light that stimulates vascularization and internal heat, ensuing in the faster recovery of wounds. The light from the photobiostimulation device affects a protein in the mitochondria of a cell, stimulates ATP production and reduces oxidative stress. As a result, it minimizing inflammation and improving tissue repair. There are various types of photobiostimulation devices are available in the photobiostimulation devices market such as infrared and red light which is categorized on the basis of wavelength they emit. Out of which the Infrared light photobiostimulation devices gain more popularity as compared to red light due to the various advantages of using such as they have shown positive results for increasing vascularization, increases deep thermal, increase in oxygenation, stimulation of the synthesis of new collagen, and improvement in skin elasticity.
Photobiostimulation devices that emit infrared light are commonly used in some of the pain management clinics and in wound healing. The main objective of manufacturing and develop the market of photobiostimulation devices is to speed up wound healing and reduce the incidences of infection in diabetic foot ulcers, specifically since there is no particular treatment for diabetic foot ulcers. There are various advantages of using photobiostimulation devices includes they are non-invasive in nature and easy to use. Recently this technique is widely used in hair transplantation therapy, where various company provide laser light treatment for hair. The company like “iRestore Laser Corporation” has launched the “iRestore” is a laser used as a hair restoration system intended to treat hereditary hair loss. Photobiostimulation device manufacturers are focusing on developing a mid-600nm red light wavelength, in line with its ability to eliminate 99% contents of a cell within minutes which develop the growth of photobiostimulation device market.
Market scope and structure analysis:
Report Metric | Details |
Market size available for years | 2020–2027 |
Base year considered | 2019 |
Forecast period | 2021–2027 |
Forecast units | Value ($USD) |
Segments covered | Type, Application, End User |
Region covered | North America (U.S., and Canada), Europe (U.K, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, India, Japan, Australia, New Zealand, and Rest of Asia-Pacific), LANTAM (Brazil, Argentina and Rest of Latin America), Middle East & Africa (South Africa and GCC) |
Companies covered | Major players analyzed include, THOR Photomedicine Ltd, Bioflex Laser Therapy, Ingeneus Pty. Ltd., iRestore Laser, LumiWave, Biolight Technologies, Omega Laser Systems, TheraDome Inc., Vielight Inc., iGrow Laser, Pulse Laser Relief, HairMa. Erchonia Corporation, Theralase Technologies, Inc. |
COVID-19 Scenario Analysis:
To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.
The ongoing outbreak of COVID-19 pandemic impacted the photobiostimulation market. It impacted on the Since the Coronavirus outbreak reached the pandemic status, the entire global supply chain has been impacted, leading the disruption in logistic capabilities and production capacity. Market player and end user losses their business due to the temporarily shutting down of industries in various region. In this situation photobiostimulation associated treatment is stopped.
Globally, North America is considered as a largest market share and dominate overall photobiostimulation devices market. This is attributed to presence of major market player, increasing awareness among the people regarding advanced technology and surgical procedure. However, Asia Pacific is considered as a second largest market share due to low cost of manufacturing photobiostimulation devices, and there are a number of researches being undertaken.
The factors that drive the growth of photobiostimulation device market such as increasing geriatric population, increasing incidence of chronic diseases, growing trend of non-invasive treatment alternatives, availability of low cost of treatment, are driving the growth of the photobiostimulation devices market. However, the factor that restrain the growth of photobiostimulation device market such as presence of fake products available in the market and stringent government for manufacturing of photobiostimulation devices are relatively lenient, therefore the lesser number of quality products available in the market
Major Key market manufacturer have been focusing on increasing research and development activities and producing new product solution for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications. In 2018, “Erchonia Corporation” has received U.S.FDA approval for the “FX 635 Laser” for treating chronic low back pain of musculoskeletal origin. The FX 635 Laser is the only FDA-approved laser in the market for chronic neck and shoulder pain treatment. In 2018, “iRestore Laser Corporation” has launched the “iRestore” is a laser used as a hair restoration system intended to treat androgenic alopecia means “hereditary hair loss”. In 2018, “Erchonia Corporation”, entered into a collaboration with “InnerScope Hearing Technologies”, and launched the “Erchonia 3LT lasers” which is used for the treatment of hearing disorders.
Key segments covered:
Segments | Sub-segments |
Type |
|
Application |
|
End User |
|
Key benefits of the report:
Questions answered in the Photobiostimulation Devices Market research report:
Key Market Segments
Segments | Sub-segments |
---|---|
By Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers